The concentration of serum HE4 was 355.2±221.29 pmol/l in ovarian cancer patients, 43.86±20.87 pmol/l in benign ovarian tumors and 30.22±9.64 pmol/l in healthy individuals. This evidence concerns the gene WFDC2 and ovarian carcinoma.